{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:29:42Z","timestamp":1787952582768,"version":"build-2784847793"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome, is a rare genetic disorder, caused by mutations in the ATRX gene. Clinical manifestations include typical facial dysmorphisms, mild-to-severe intellectual disability, hypotonia, genital anomalies, significant gastrointestinal (GI) complications, such as abdominal distension, chronic constipation, feeding difficulties, gastroesophageal reflux, and mild-to-moderate anemia secondary to alpha-thalassemia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a patient with ATR-X syndrome suffering from gastrointestinal dysmotility and highlight the beneficial effects of pyridostigmine. Knowledge about the role and appropriate dosage of pyridostigmine in GI motility disorders is limited. To date, only nine pediatric cases involving pyridostigmine for GI dysmotility have been reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Considering current understanding about the treatment of gastrointestinal complications in patients with genetic syndromes, this case provides new insights into management of these complex clinical presentations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1460658","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T06:23:08Z","timestamp":1734416588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Pyridostigmine as a therapeutic option for pediatric gastrointestinal dysmotilities in ATR-X syndrome. Case report and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"F. F.","family":"Comisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Soddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Corpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cacace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Foiadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Savasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1002\/ajmg.a.37252","article-title":"Volvulus and bowel obstruction in ATR-X syndrome-clinical report and review of literature","author":"Horesh","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1056\/NEJM198109103051103","article-title":"Hemoglobin H disease and mental retardation: a new syndrome or a remarkable coincidence?","volume":"305","author":"Weatherall","year":"1981","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0092-8674(95)90287-2","article-title":"Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)","volume":"80","author":"Gibbons","year":"1995","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00439-021-02361-5","article-title":"ATR-X syndrome: genetics, clinical spectrum, and management","volume":"140","author":"Le\u00f3n","year":"2021","journal-title":"Hum Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1172-1-15","article-title":"Alpha thalassaemia-mental retardation, X linked","volume":"1","author":"Gibbons","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"B6","article-title":"Alpha-Thalassemia X-linked intellectual disability syndrome. [Initial Posting: June 19, 2000; Last Update: May 28, 2020]","volume-title":"GeneReviews\u00ae","author":"Stevenson","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"e43781","DOI":"10.7759\/cureus.43781","article-title":"Unusual inconsolable crying: an insight, case report, and review of the literature on the pitt-hopkins gastrointestinal phenotype","volume":"15","author":"Comisi","year":"2023","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/ajmg.a.62917","article-title":"Prevalence of gastrointestinal disorders in individuals with RASopathies: may RAS\/MAP\/ERK pathway dysfunctions be a model of neuropathic pain and visceral hypersensitivity?","volume":"188","author":"Leoni","year":"2022","journal-title":"Am J Med Genet A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/ajmg.a.31248","article-title":"Gastrointestinal phenotype of ATR-X syndrome","volume":"140","author":"Martucciello","year":"2006","journal-title":"Am J Med Genet A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/1096-8628(200023)97:3%3C204::AID-AJMG1038%3E3.0.CO;2-X","article-title":"Molecular-clinical spectrum of the ATR-X syndrome","volume":"97","author":"Gibbons","year":"2000","journal-title":"Am J Med Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1111\/ped.12402","article-title":"Esophago-gastric motility and nutritional management in a child with ATR-X syndrome","volume":"56","author":"Watanabe","year":"2014","journal-title":"Pediatr Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/11593300-000000000-00000","article-title":"Treatment of myasthenia gravis: focus on pyridostigmine","volume":"31","author":"Maggi","year":"2011","journal-title":"Clin Drug Investig"},{"key":"B13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5056\/jnm19078","article-title":"Pyridostigmine in pediatric intestinal Pseudo-obstruction: case report of a 2-year old girl and literature review","volume":"25","author":"Di Nardo","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"B14","first-page":"195","article-title":"An unusual presentation of gastrointestinal obstruction in a three-year-old boy","volume":"51","author":"Boybeyi","year":"2009","journal-title":"Turk J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40272-017-0277-6","article-title":"Application of pyridostigmine in pediatric gastrointestinal motility disorders: a case series","volume":"20","author":"Manini","year":"2018","journal-title":"Paediatr Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S404","DOI":"10.1542\/peds.2017-0007","article-title":"The use of pyridostigmine in a child with chronic intestinal Pseudo-obstruction","volume":"141","author":"Choudhury","year":"2018","journal-title":"Pediatrics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1097\/MPG.0000000000002183","article-title":"Oral pyridostigmine-responsive visceral myopathy with ACTG2 mutations: a case series","volume":"68","author":"Lee","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1460658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T06:23:10Z","timestamp":1734416590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1460658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":17,"alternative-id":["10.3389\/fped.2024.1460658"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1460658","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"article-number":"1460658"}}